Key facts
- Bioprime’s last known valuation is $12.2M.
- It has raised $8.8M; the latest was Later Stage VC ($6.0M) in Oct 2024.
- Notable investors include BIRAC, Venture Center, AIC ISB, Edaphon, I-Venture @ISB — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Bioprime
- ·The full record, as it builds
Funding rounds
No funding rounds for Bioprime are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bioprime
Developer of bio-based technologies designed to aid the discovery of small molecules and microbes for the agriculture industry. The company's platform develops a systems-biology approach that combines research in plant physiology, biochemistry, ecology, and microbiomes, to develop innovative biologicals, to revolutionize agriculture and transform the lives of millions of farmers globally, promoting soil restoration and health, enabling farmers to effectively eliminate crop loss, temperature fluctuations, drought, resilient insects and diseases.
- Sector
- Materials and Resources
- HQ
- Pune, India
- Founded
- 2016
- Employees
- 76
- Website
- bioprimeagri.com/
- Ownership
- Privately Held (backing)
Bioprime doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bioprime shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bioprime in its N-PORT filings yet. We sweep new filings monthly.